The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...

THAT IS WHAT WOULD MAKE THIS TREATMENT ACCESSIBLE TO ANYONE. ACCORDING TO DOCTOR BOLI. THE REASON WE USE UMBILICAL CORD CELLS IS THAT WE HAVE FOUND IN PRECLINICAL STUDIES THAT THEY MULTIPLY MUCH ...

Stem cell therapy is crucial for Lydia, diagnosed with cerebral palsy due to a loss of brain matter that cannot regenerate.

RegeneCyte is an allogeneic human umbilical cord blood-derived hematopoietic stem cell therapy. These hematopoietic progenitor cells divide and mature from the bone marrow and get released into ...

Backed by science and real results, Swiss Medica is leading the way in regenerative stem cell therapies with personalized treatments that go beyond symptom management to restore function and quality ...

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

Immorta Bio Inc., a scientific longevity company, announced today that it has published, in the Peer-Reviewed Journal of Stem Cell Research & Therapeutics, data demonstrating that intravenous ...

Now they’re trying to translate that into a treatment ... usually taken from bone marrow, fat, or umbilical cord blood. Proangiogenic progenitor cells: These are in blood and bone marrow.

Storing of stem cells through cord cells and preserving umbilical cord is being opted ... centre for bone marrow transplant & cellular therapy, and senior consultant, paediatric hematology ...